. Author manuscript; available in PMC: 2011 Feb 1.

Published in final edited form as: Neurochem Int. 2009 Dec 22;56(3):501–507. doi: 10.1016/j.neuint.2009.12.010

Table 1.

Concentration of plasma and brain non-esterified fatty acids, and brain acyl-CoA in control and LPS-treated rats

	Plasma Non-esterified Fatty Acid (nmol/ml)		Brain Non-esterified Fatty Acid (nmol/g)		Brain Acyl-CoA (nmol/g)

Fatty Acid	Control	LPS	Control	LPS	Control	LPS

Palmitate (16:0)	266.1 ± 95.6	283.1 ± 53.7	25.9 ± 10.3	26.8 ± 5.7	29.0 ± 6.7	34.6 ± 10.0
Stearate (18:0)	72.2 ± 42.6	81.0 ± 21.3	77.7 ± 12.3	60.9 ± 17.7	5.0 ± 3.8	8.4 ± 4.7
Oleate (18:1n-9)	221.4 ± 82.8	214.3 ± 51.0	62.0 ± 10.1	65.2 ± 9.1	27.6 ± 8.0	30.4 ± 8.7
Linoleate (18:2n-6)	277.2 ± 62.6	296.3 ± 77.3	6.2 ± 2.7	8.3 ± 3.0	10.4 ± 3.0	14.3 ± 10.2
Arachidonate (20:4n-6)	20.9 ± 7.3	26.2 ± 7.0	4.6 ± 0.5	^*15.8 ± 5.4	1.8 ± 0.8	1.3 ± 1.0
Docosahexaenoate (22:6n-3)	9.4 ± 4.6	9.1 ± 3.9	4.2 ± 0.8	5.3 ± 1.2	1.5 ± 0.8	2.1 ± 0.7

Values are means ± SD (n = 7).

p < 0.05, differs from control mean.